NCT00427232View on ClinicalTrials.gov

Endothelin-Receptor Blockade in Coronary Heart Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

August 31, 2006

Conditions
Coronary VesselsEndothelinsVascular Resistance
Interventions
DRUG

BQ-123 and BQ-788

Trial Locations (1)

A-1090

Dept. of Internal Medicine II, Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT00427232 - Endothelin-Receptor Blockade in Coronary Heart Disease | Biotech Hunter | Biotech Hunter